Published in Pediatr Infect Dis J on January 01, 2015
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58
Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis (2005) 1.36
Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29
Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis (2007) 1.27
Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis (2005) 1.22
Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine (2012) 1.21
Hospital-Based Surveillance of Rotavirus Diarrhea in the People's Republic of China, August 2003-July 2007. J Infect Dis (2009) 1.19
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009. Clin Infect Dis (2012) 1.12
A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2 years of age. Acta Paediatr Scand (1991) 1.03
Clinical features of acute infantile gastroenteritis associated with human rotavirus subgroups I and II. J Clin Microbiol (1988) 1.01
Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China. Vaccine (2011) 0.96
Importance and challenges of accurately counting rotavirus deaths in China, 2002. Vaccine (2009) 0.96
Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines (2007) 0.92
Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes. Pediatr Infect Dis J (2014) 0.92
The incidence and direct medical cost of hospitalization due to rotavirus gastroenteritis in Kyoto, Japan, as estimated from a retrospective hospital study. Vaccine (2011) 0.91
Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update. Hum Vaccin (2010) 0.89
Epidemiology and burden of rotavirus infection among children in Hangzhou, China. J Clin Virol (2010) 0.88
Rotavirus infection in Hong Kong: epidemiology and estimates of disease burden. Epidemiol Infect (1998) 0.87
Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis. Vaccine (2014) 0.86
Severity of rotavirus gastroenteritis in Indian children requiring hospitalization. Vaccine (2012) 0.85
Burden of rotavirus gastroenteritis in children <5 years of age in Greece: hospital-based prospective surveillance (2008-2010). BMJ Open (2013) 0.82
Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease. Vaccine (2012) 0.82
[Whole genome analysis of human group A rotavirus G9p[8] strains in Hebei lulong region, 2009-2011]. Bing Du Xue Bao (2014) 0.78
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med (2011) 4.49
Noroviruses: a comprehensive review. J Clin Virol (2008) 4.33
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med (2013) 4.09
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2009) 3.08
Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis (2010) 3.02
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med (2006) 2.99
Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). J Med Chem (2011) 2.97
Norovirus disease in the United States. Emerg Infect Dis (2013) 2.92
Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis (2009) 2.50
The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet (2004) 2.43
Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis (2011) 2.43
Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med (2011) 2.41
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
Surveillance for foodborne disease outbreaks - United States, 1998-2008. MMWR Surveill Summ (2013) 2.27
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. N Engl J Med (2006) 1.99
Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis (2011) 1.98
Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis (2011) 1.97
Outbreaks of acute gastroenteritis transmitted by person-to-person contact--United States, 2009-2010. MMWR Surveill Summ (2012) 1.94
Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis (2011) 1.92
Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89
Environmental transmission of norovirus gastroenteritis. Curr Opin Virol (2011) 1.87
Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis (2012) 1.86
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics (2009) 1.84
United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83
Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol (2008) 1.81
Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clin Infect Dis (2011) 1.79
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78
Specific threonine phosphorylation of a host target by two unrelated type III effectors activates a host innate immune receptor in plants. Cell Host Microbe (2011) 1.76
Rotavirus vaccines: successes and challenges. J Infect (2013) 1.74
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis (2009) 1.72
Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg Infect Dis (2012) 1.69
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ (2012) 1.69
Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol (2005) 1.65
Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis (2011) 1.64
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2012) 1.64
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
The global burden of diarrhoeal disease in children. Bull World Health Organ (2003) 1.61
Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics (2010) 1.59
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58
Disease transmission and passenger behaviors during a high morbidity Norovirus outbreak on a cruise ship, January 2009. Clin Infect Dis (2011) 1.56
The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One (2011) 1.54
Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol (2011) 1.52
Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52
Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis (2010) 1.51
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis (2004) 1.49
Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49
Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis (2013) 1.49
Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis (2012) 1.48
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48
A strong constitutive ethylene-response phenotype conferred on Arabidopsis plants containing null mutations in the ethylene receptors ETR1 and ERS1. BMC Plant Biol (2007) 1.48
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Should India launch a national immunisation programme against rotavirus? Yes. BMJ (2012) 1.43
OCT assessment of allograft vasculopathy in heart transplant recipients. JACC Cardiovasc Imaging (2012) 1.43
Recombination form and epidemiology of HIV-1 unique recombinant strains identified in Yunnan, China. PLoS One (2012) 1.43
Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine (2010) 1.43
Descriptive epidemiology of fatal respiratory outbreaks and detection of a human-related metapneumovirus in wild chimpanzees (Pan troglodytes) at Mahale Mountains National Park, Western Tanzania. Am J Primatol (2008) 1.42
Survey of wildlife rehabilitators regarding rabies vector species. J Am Vet Med Assoc (2005) 1.42
Identification of a novel HIV type 1 circulating recombinant form (CRF52_01B) in Southeast Asia. AIDS Res Hum Retroviruses (2012) 1.42
Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J (2011) 1.41
Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci (2011) 1.41
Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis (2014) 1.40
Synthesis, characterization, antioxidant activities, and DNA-binding studies of (E)-N'-[1-(pyridin-2-yl)ethylidene]isonicotinohydrazide and its Pr(III) and Nd(III) complexes. Chem Pharm Bull (Tokyo) (2010) 1.40